The Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn disease in adults.

Sales of Eli Lilly's lead drug, tirzepatide, which it markets as Zepbound for weight loss and Mounjaro for diabetes, leapt up to a combined $5.4 billion in the fourth quarter. That's some amazing ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 472.57% and ...

The FDA has approved Omvoh (mirikizumab-mrkz) for treating moderately to severely active Crohn’s disease in adults. Clinical ...

Omvoh (mirikizumab-mrkz) for moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for ...

The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...

The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely ...

More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...

The bad news kept coming for Madison LeCroy and her husband Brett Randle. After revealing earlier in the season that 38-year-old Brett had been diagnosed with thyroid cancer in late 2023, Madison, 34, ...

What Is White Matter Disease? White matter disease is the wearing away of tissue in the largest and deepest part of your brain. The loss of white matter function has a number of causes ...

Since then, I think it's fair to say that most people have been nervous about the emergence of the next big infectious disease—be that a virus, bacterium, fungus or parasite. With COVID in ...